skip to main content


Search for: All records

Creators/Authors contains: "Heiser, N."

Note: When clicking on a Digital Object Identifier (DOI) number, you will be taken to an external site maintained by the publisher. Some full text articles may not yet be available without a charge during the embargo (administrative interval).
What is a DOI Number?

Some links on this page may take you to non-federal websites. Their policies may differ from this site.

  1. A method using strong anion exchange solid phase extraction (SAX-SPE) followed by liquid chromatography ultraviolet detection (LC-UV) for the analysis of phenylbutazone (PBZ) and its metabolite oxyphenbutazone (OPBZ) in equine plasma for doping control in horse racing has been developed. By using SAX-SPE, commonly regulated non-steroidal anti-inflammatory drugs (NSAIDs) by the United States Equestrian Federation (USEF), i.e. PBZ, OPBZ, diclofenac, flunixin, ketoprofen, meclofenamic acid and naproxen, and an internal standard, i.e. tolfenamic acid, were first selectively extracted. Then, baseline separation of PBZ, OPBZ from other NSAIDs, internal standard, and residual components of equine plasma was achieved using LC-UV. Finally, PBZ and OPBZ in equine plasma were quantified after an internal calibration curve was created. 
    more » « less